Trial: 201809107

AALL1631 – International Phase 3 trial in Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) testing imatinib in combination with two different cytotoxic chemotherapy backbones

Phase

III

Principal Investigator

Hayashi, Robert

Disease Site

Lymphoid Leukemia

Learn more about this study at: clinicaltrials.gov